ArticleLeukemia2025

Characterization of E1 enzyme dependencies in mutant-UBA1 human cells reveals UBA6 as a novel therapeutic target in VEXAS syndrome.

Courtnee A Clough et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.